GlassScriptPhysician profile
Min Zhu
NPI 1679513667
$816.32
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $555 · 2020: $83.72 · 2021: $138 · 2022: $39.73.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $216.30 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $124.99 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $121.41 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $96.87 | 2021 | |
| Alexion Pharmaceuticals, INC. | $70.40 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $24.95 | 2019 | |
| Amneal Pharmaceuticals LLC | $20.79 | 2019 | |
| Lundbeck LLC | $20.13 | 2020 | |
| Shire North American Group INC | $19.46 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $19.42 | 2020 | |
| Neurocrine Biosciences, INC. | $19.35 | 2019 | |
| Amgen INC. | $17.96 | 2019 | |
| Tanabe Pharma America, INC. | $16.56 | 2019 | |
| Lilly USA, LLC | $13.95 | 2019 | |
| Genentech USA, INC. | $13.78 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Min Zhu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.